Antiplatelet agents: an overview
Journal of the Arab Society for Medical Research, 2023 Platelets play a major role in normal hemostatic and thrombotic processes. Aggregation of platelets presents the key pathophysiological step in the development of cardiovascular diseases; hence, antiplatelet agents remain crucial in the treatment of ...
Asma Haffouz +2 more
doaj +2 more sources
Effect of Antiplatelet Agents on Abdominal Aortic Aneurysm Process: A Systematic Review and Meta-Analysis [PDF]
Reviews in Cardiovascular Medicine, 2023 Background: This systematic review and meta-analysis aims to investigate whether antiplatelet agents are associated with the reduction, expansion, and rupture of abdominal aortic aneurysm (AAA).
Yang Yang +5 more
doaj +2 more sources
Association between osteoporosis or osteopenia and taking antiplatelet agents in general US population of NHANES [PDF]
Frontiers in Endocrinology, 2022 BackgroundOsteoporosis (OP) and osteopenia are common bone disorders in old age, and lots of patients suffering from OP or osteopenia need to take antiplatelet agents to treat basic diseases.
Hao Lv +7 more
doaj +2 more sources
Concomitant Use of Antiplatelet Agents and Proton-Pump Inhibitors Increases the Risk of Adverse Cardiovascular Events: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions [PDF]
Journal of Cardiovascular Development and Disease, 2023 Antiplatelet agents are commonly used in combination with proton-pump inhibitors (PPIs) in patients with acute coronary syndrome who are at risk of gastrointestinal hemorrhage.
Hee Gyu Yang, Dong-Kyu Kim
doaj +2 more sources
The association of antiplatelet agents with mortality among patients with non–COVID-19 community-acquired pneumonia: a systematic review and meta-analysis [PDF]
Research and Practice in Thrombosis and HaemostasisBackground: Community-acquired pneumonia (CAP) triggers inflammatory and thrombotic host responses driving morbidity and mortality. Antiplatelet agents may favorably modulate these pathways; however, their role in non–COVID-19 CAP remains uncertain ...
Sylvain A. Lother +21 more
doaj +2 more sources
Association of antiplatelet agents and intracranial hemorrhage in geriatric emergency department patients with head trauma from a fall [PDF]
Trauma Surgery & Acute Care OpenBackground Older adults have the highest incidence of traumatic brain injury and are often on antiplatelet therapy. This study examines the association between preinjury antiplatelet agent use and intracranial hemorrhage in geriatric emergency department
Mike Wells +10 more
doaj +2 more sources
Editorial: Antiplatelet Agents in Stroke Prevention [PDF]
Frontiers in Neurology, 2021 Gergely Feher +5 more
doaj +2 more sources
Antiplatelet therapy in stroke prevention after non-cardioembolic transient ischemic attack
Неврология, нейропсихиатрия, психосоматика, 2021 The review shows modern concepts on the role of antiplatelet therapy in the secondary prevention of cardiovascular diseases in patients after non-cardioembolic ischemic stroke or transient ischemic attack (TIA). We present an analytical characteristic of
A. V. Fonyakin +2 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Although antiplatelet agents are frequently prescribed in moyamoya disease in routine clinical practice, there are no large‐scale epidemiologic trials or randomized trial evidence to support their use in patients with moyamoya disease. Methods
Woo‐Keun Seo +7 more
doaj +1 more source
PLoS ONE, 2021 BackgroundThe interaction between smoking and the use of antiplatelet agents on the prognosis of vasospastic angina (VA) is rarely investigated.MethodsVA-Korea is a nation-wide multi-center registry with prospective design (n = 1812).
Seong-Sik Cho +15 more
doaj +1 more source